Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Affect Disord ; 335: 484-492, 2023 08 15.
Artigo em Inglês | MEDLINE | ID: mdl-37201900

RESUMO

INTRODUCTION: Ketamine intravenous therapy (KIT) appears effective for treating depression in controlled trials testing a short series of infusions. A rapidly proliferating number of clinics offer KIT for depression and anxiety, using protocols without a strong evidence basis. Controlled comparison of mood and anxiety from real-world KIT clinics, and the stability of outcomes, is lacking. METHODS: We performed a retrospective controlled analysis on patients treated with KIT in ten community clinics across the US, between 08/2017-03/2020. Depression and anxiety symptoms were evaluated using the Quick Inventory of Depressive Symptomatology-Self Report 16-item (QIDS) and the Generalized Anxiety Disorder 7-item (GAD-7) scales, respectively. Comparison data sets from patients who did not undergo KIT were obtained from previously published real-world studies. RESULTS: Of 2758 patients treated, 714 and 836 met criteria for analysis of KIT induction and maintenance outcomes, respectively. Patients exhibited significant and concordant reduction in both anxiety and depression symptoms after induction (Cohen's d = -1.17 and d = -1.56, respectively). Compared to two external datasets of KIT-naive depressed patients or patients starting standard antidepressant therapy, KIT patients experienced a significantly greater reduction in depression symptoms at eight weeks (Cohen's d = -1.03 and d = -0.62 respectively). Furthermore, we identified a subpopulation of late-responders. During maintenance, up to a year post-induction, increases in symptoms were minimal. LIMITATIONS: Due to the retrospective nature of the analyses, interpreting this dataset is limited by incomplete patient information and sample attrition. CONCLUSIONS: KIT treatment elicited robust symptomatic relief that remained stable up to one year of follow-up.


Assuntos
Ketamina , Humanos , Depressão/tratamento farmacológico , Estudos Retrospectivos , Transtornos de Ansiedade/tratamento farmacológico , Ansiedade/tratamento farmacológico
2.
Curr Med Res Opin ; 38(12): 2219-2226, 2022 12.
Artigo em Inglês | MEDLINE | ID: mdl-36106382

RESUMO

OBJECTIVE: This study describes treatment patterns, productivity, healthcare resource utilization and previous episodes of depression for patients with treatment-resistant depression (TRD). METHODS: In this cross-sectional study, a quantitative survey was administered to 225 healthcare providers (HCPs) distributed evenly across Germany, France and the UK from July to August 2021. Each HCP was asked to answer based on medical records of five patients with TRD, defined as patients failing to respond to two or more treatments of adequate dose and duration in the same episode of major depressive disorder (MDD), which provided a sample size of 1125 patients. RESULTS: Of the 1125 patients with TRD, 73.2% had two or more previous episodes of MDD, 46.3% had a history of suicidal ideation and 24.8% had attempted suicide. Only 26.8% of patients were employed either full-time or part-time. During the most recent/current TRD episode, 45.5% of patients received five or more lines of treatment, and 46.0% remained on monotherapy. For multiple pharmacological treatments, too many distinct combinations were used to discern trends. Overall, 60.6% of patients had at least one mental health-related hospitalization in the last 12 months; 35.0% had two or more hospitalizations. Half of TRD patients saw a doctor five or more times per year for their depression. CONCLUSIONS: This study addresses the knowledge gap about treatment patterns and healthcare utilization in real-world practice for TRD patients in three European countries. It provides data that potentially could inform treatment guideline development and optimize patient-perceived benefits from the treatment of TRD.


Assuntos
Transtorno Depressivo Maior , Transtorno Depressivo Resistente a Tratamento , Humanos , Transtorno Depressivo Maior/tratamento farmacológico , Transtorno Depressivo Maior/epidemiologia , Depressão/tratamento farmacológico , Depressão/epidemiologia , Estudos Transversais , Antidepressivos/uso terapêutico , Estudos Retrospectivos , Alemanha , Atenção à Saúde , Pessoal de Saúde
4.
Appl Occup Environ Hyg ; 17(12): 878-90, 2002 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12495599

RESUMO

This article is a critical review of some of the methods that have been used for the sampling, analysis, and monitoring of vapor-phase toluene diisocyanate (TDI). Only some of the methods that have received relatively widespread application have been addressed in this article. This review includes a "tutorial style" discussion of basic definitions and basic principles and procedures of quality control and metrology for sampling, analysis, and monitoring. One critical issue that is addressed: Are there methods and monitoring instruments available that are capable of sampling and analyzing or monitoring TDI vapor with sufficient speed and sensitivity to satisfy the requirements of the current ACGIH threshold limit values (TLVs) for TDI vapor?


Assuntos
Poluentes Ocupacionais do Ar/análise , Monitoramento Ambiental/instrumentação , Monitoramento Ambiental/métodos , Exposição Ocupacional/prevenção & controle , Tolueno 2,4-Di-Isocianato/análise , Humanos , Controle de Qualidade
5.
J Air Waste Manag Assoc ; 49(2): 114-124, 1999 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-28085654

RESUMO

In open-path Fourier Transform Infrared spectroscopy, the generation of a suitable background single-beam spectrum is of major concern. The Shifting Method is a derivative-like approach to correct for the background without the need to actually measure a background spectrum using the sample single-beam spectrum. A thorough study of the Shifting Method was conducted. A set of guidelines was developed based on the results of artificial and closed cell data. These guidelines were applied to three different data sets, consisting of cell and open path data with multiple compounds, overlapping peaks, and high water vapor and aerosol levels.

6.
J Air Waste Manag Assoc ; 46(8): 761-764, 1996 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28067134

RESUMO

International cooperation and diffusion of environmental technologies is a central goal of the U.S. EPA Environmental Technology Initiative, and is of great interest to many countries. One objective is to exchange knowledge and skills concerning new monitoring technologies. In this case, the technology was open path Fourier Transform Infrared Spectrometry (op-FTIR). Taiwan is a high-technology, newly industrialized country. Because of air pollution problems, it is interested in obtaining skills, knowledge, and instrumentation for monitoring air pollutants. In April 1994, the Industrial Technology Research Institute, Center for Industrial Safety and Health Technology (ITRI/CISH) in Hsinchu, Taiwan, requested intensive training in op-FTIR. Training was held between September 30,1994 and October 29,1994. During the stay, the instructor provided intensive training on op-FTIR theory as well as an introduction to available instrumentation and software. The training concluded with a field demonstration of the instrumentation in a manufacturing facility. This report gives an overview of the training methods, structure, and materials in the op-FTIR training course. It will also address various problems encountered while teaching this course. In addition, the potential use for this technology in industry as well as by the Taiwanese government will be explained.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA